Several studies have implicated RUNX3 in the development of immune-related diseases including Crohn’s disease, ankylosing spondylitis, psoriasis and ulcerative colitis (reviewed in [33]), and SNPs which disrupt RUNX binding sites have also been associated with RA [32, 34]. Here, RUNX3 is linked to psoriasis.